RxDoctor Payments Data

Peter Boulos

Interventional Cardiology · Lafayette, CONPI 1013375724

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Edwards Lifesciences at 35.9% of the total. That places this record below the midpoint for interventional cardiology clinicians in CO, where the typical reported total is $6,820.

$8,027in general payments, 2019–2025

Across 107 payments — averaging $75.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$3K
  • Medtronic$2K
  • Abbott$2K
  • Boston Scientific$644
  • Astellas Pharma US Inc$354
  • Abiomed$227
  • plus $640 from 10 others

What the payments were for

  • Travel & lodging$3,61545%
  • Food & beverage$3,55044%
  • Education$86211%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,027 in reported general payments places this provider in the 50th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado

Other interventional cardiology in Lafayette

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →